101
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Incidence and Clinical Significance of Bcl-2 / IgH Rearrangements in Follicular Lymphoma

, , , , , , , , & show all
Pages 71-76 | Published online: 01 Jul 2009

  • The Non-Hodgkin's Lymphoma Classification Project (1997) "A clinical evaluation of the International Lymphorna Study Group classification of non-Hodgkin's lymphoma", Blood 89, 3909-3918.
  • Weiss, L.M., Warnke, R.A., Sklar, J. and Cleary, M.L. (1987) "Molecular analysis of the t(14:18) chromosomal translocation in malignant lymphomas", New England Journal of Medicine 317, 1185-1189.
  • Yunis, J.J., Frizzera, G., Oken, M.M., et al. (1987) "Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer", New England Journal of Medicine 316, 79-84.
  • Vaandrager, J.W., Schuuring, E., Raap, T., et al. (2000) "Interphase FISH detection of BCL-2 rearrangement in follicular lymphoma using breakpoint-flanking probes", Genes, Chromosomes and Cancer 27, 85-94.
  • Amakaya, R., Fukuhara, S., Ohno, H., et al. (1989) "Involvement of bcl-2 gene in Japanese follicular lymphoma", Blood 73, 787-791.
  • Takechi, M., Tanaka, K., Hashimoto, T., et al. (1991) "Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients", Leukemia 5, 1069-1075.
  • Johnson, A., Brun, A., Dictor, M., et al. (1995) "Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade. A report from southern Sweden", Annals of Oncology 6, 789-794.
  • Pezella, F., Ralfkiaer, E., Gatter, K.C. and Mason, D.Y. (1990) "The (14;18) translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction", British Journal of Haematology 76, 58-64.
  • Miettinem, M. and Lasota, J. (1997) "Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--Performance in formaldehyde-fixed issue and application in clinical problem cases", Pathology Research and Practice 193, 9-19.
  • Segal, G.H., Jorgensen, T., Scott, M. and Braylan, R.C. (1994) "Optimal primer selection for clonality assessment by polymerase chain reaction analysis: follicular lymphomas", Human Pathology 25, 1276-1282.
  • Horsman, D.E., Gascoyne, R.D., Coupland, R.W., et al. (1995) "Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma", American Journal of Clinical Pathology 103, 472-478.
  • Seite, P., Hillion, J., D' Agay, M.E., et al. (1993) "Bcl-2 gene activation and protein expression in follicular lymphoma: a report on 64 cases", Leukemia 7, 410-417.
  • Lee, M.S., Blick, M.B., Pathak, S., et al. (1987) "The gene located at chromosome 18 band q2l is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas", Blood 70, 90-95.
  • Hill, M.E., MacLennan, K.A., Cunningham, D.C., et al. (1996) "Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study", Blood 88, 1046-1051.
  • Hermine, O., Haioun, C., Lepage, E., et al. (1996) "Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma", Blood 87, 265-272.
  • Gascoyne, R.D., Adomat, S.A., Krajewski, S., et al. (1997) "Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood 90, 244-251.
  • Kramer, M.H.H., Hermans, J., Parker, J., et al. (1996) "Clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study", Journal of Clinical Oncology 14, 2131-2138.
  • Yunis, J.J., Mayer, M.G., Arnesen, M.A., Aeppli, O.P., et al. (1989) "Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma", New England of Journal Medicine 320, 1047-1054.
  • López-Guillermo, A., Cabanillas, F., McDonnell, T.L, et al. (1999) "Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphomas", Blood 93, 3081-3087.
  • Pezella, F., Jones, M., Ralfkiaer, E., Ersboll, J., et al. (1992) "Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma", British Journal of Cancer 65, 87-89.
  • Harris, N.L., Jaffe, E.S., Stein, H., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
  • Pinyol, M., Campo, E., Nadal, A., et al. (1996) "Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction", American Journal of Clinical Pathology 105, 532-537.
  • Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) "A simple salting out procedure for extracting DNA from human nucleated cells", Nucleic Acids Research 16, 1215.
  • Segal, G.H., Scott, M. and Braylan, R.C. (1996) "Semi-automated ELISA-based detection system for verifying the authenticity of amplified t(14;18)-containing products", Diagnostic Molecular Pathology 5, 114-120.
  • Gribben, J.G., Freedman, A.S., Woo, S.D., et al. (1991) "All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment", Blood 78, 3275-3280.
  • Ngan, B.Y., Nourse, J. and Cleary, M.L. (1989) "Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas", Blood 73, 1759-1762.
  • Kaplan, G.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Journal of the American Statistical Association 53, 457-481.
  • Peto, R. and Pike, M.C. (1973) "Conservatism of the S(0-E)2/E in the log-rank test for survival data on tumor incidence data", Biometrics 29, 759-784.
  • Colombat, P., Salles, G., Brousse, N., et al. (2001) "Rituximab (antiCD20 monoclonal antibody) as single first-line therapy for patients follicular lymphoma with a low tumor burden: clinical and molecular evaluation", Blood 97, 101-106.
  • Crescenzi, M., Seto, M., Herzig, G.P., et al. (1988) "Thermoestable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease", Proceedings of the National Academy of Science USA 85, 4869-4873.
  • Levine, E.G., Arthur, D.C., Frizzera, G., et al. (1988) "Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma", Annals of Internal Medicine 108, 14-20.
  • Tilly, H., Rossi, A., Stamatoullas, A., et al. (1994) "Prognostic values of chromosomal abnormalities in follicular lymphoma", Blood 84, 1043-1049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.